Artelo Biosciences to Present at the H.C. Wainwright Global Investment Conference on May 24th May 16, 2022 8:55am EDT
Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th May 13, 2022 8:30am EDT
Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update May 12, 2022 8:30am EDT
Artelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New York Apr 25, 2022 7:30am EDT
Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia Apr 13, 2022 8:30am EDT
Artelo Expands Collaboration with Trinity College Dublin to Investigate Cellular Biology of Fatty Acid Binding Protein (FABP) Inhibition In Cancer Mar 28, 2022 9:25am EDT
Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th Mar 22, 2022 9:00am EDT
Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update Mar 21, 2022 8:30am EDT
Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol Mar 02, 2022 8:30am EST
Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update Jan 12, 2022 8:30am EST
